Risk-based and diagnostics-linked personalized medicine for cancer

By Srivastava Sudhir   Wagner Paul D  

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 33-43

Future Medicine

Access to resources Recommend Favorite

Diagnostics for personalized medicine: what will change in the era of large-scale genomics studies?

By Grewal Anoop   Stephan Dietrich A  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 835-848

Future Medicine

Access to resources Recommend Favorite

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and validation of risk models and molecular diagnostics to permit personalized management of cancer

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics

By Issa Amalia M   Tufail Waqas   Atehortua Nelson   McKeever John  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite